BrainsWay Ltd. (BWAY)

5.56 +0.31 (+5.90%) At close: 04:00PM EDT

BrainsWay Ltd.

Bynet Building
3rd Floor 19 Hartum Street Har Hotzvim
Jerusalem 9777518
Israel
972-2-582-4030
https://www.brainsway.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 134

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Hadar Levy	Chief Executive Officer	434k	N/A	1974
Mr. Avner Hagai	Founder & Director	43.65k	N/A	1956
Prof. Abraham Zangen	Co-Founder, Member of Scientific Advisory Board & Director	72.17k	N/A	1970
Mr. Christopher J. Boyer Ph.D.	Vice President of Global Marketing	292k	N/A	1978
Dr. Yiftach Roth Ph.D.	Founder & Chief Scientific Officer	108k	N/A	1971
Mr. Ido Marom	Chief Financial Officer	N/A	N/A	1976
Mr. Menachem C. Klein Esq.	VP, General Counsel & Corporate Secretary	N/A	N/A	N/A
Dr. Aron Tendler	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Corporate governance

BrainsWay Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.